Which of the following is NOT used topically for ophthalmic use?
5% guanethidine is used for which of the following conditions?
Steroids are contraindicated in which of the following conditions?
Angiography of choroidal melanoma shows which of the following appearances?
Which of the following drugs can be used topically in the eye?
Which short-acting mydriatic is used for fundoscopy?
Topical steroid is contraindicated in which ocular condition?
What is the topical antifungal agent of choice for treating corneal fungal infections?
What is the effect of Epinephrine on aqueous humor dynamics?
In a case of hypertensive uveitis, what is the most useful drug to reduce intraocular pressure?
Explanation: **Explanation:** The correct answer is **Methylprednisolone**. **1. Why Methylprednisolone is the correct answer:** In ophthalmology, corticosteroids are used topically to treat non-infectious inflammatory conditions. While Methylprednisolone is a potent intermediate-acting corticosteroid frequently used systemically (IV/Oral) or via **sub-Tenon/intraocular injection**, it is **not available as a topical ophthalmic drop or ointment**. This is primarily due to its poor corneal penetration and the availability of more effective topical alternatives. **2. Why the other options are incorrect:** * **Prednisolone (Option B):** Specifically **Prednisolone Acetate (1%)**, is the "gold standard" topical steroid for intraocular inflammation (uveitis) due to its superior lipophilic properties and excellent corneal penetration. * **Dexamethasone (Option D):** A highly potent long-acting steroid commonly used topically (0.1%) for post-operative inflammation and surface allergies. * **Hydrocortisone (Option A):** A low-potency steroid used topically, primarily for mild ocular surface or eyelid inflammation (e.g., allergic blepharitis), as it has a lower risk of inducing a significant rise in intraocular pressure (IOP). **3. High-Yield Clinical Pearls for NEET-PG:** * **Steroid-Induced Glaucoma:** Topical steroids can increase IOP by decreasing aqueous outflow through the trabecular meshwork. **Dexamethasone** is a high-potency "strong" steroid with a high risk, while **Fluorometholone** and **Loteprednol** are "soft" steroids with a lower risk of IOP spikes. * **Contraindication:** Topical steroids are strictly contraindicated in **Herpetic Dendritic Ulcers** (epithelial keratitis) as they promote viral replication and can lead to geographic ulcers. * **Side Effects:** Long-term topical steroid use is associated with **Posterior Subcapsular Cataracts (PSC)** and secondary glaucoma.
Explanation: **Explanation:** **Correct Answer: C. Thyrotoxic ophthalmopathy** **Mechanism and Rationale:** Guanethidine is a sympatholytic agent that acts by depleting norepinephrine from postganglionic sympathetic nerve endings. In **Thyrotoxic ophthalmopathy (Graves' Orbitopathy)**, there is excessive sympathetic stimulation of **Müller’s muscle** (a smooth muscle in the upper eyelid), leading to lid retraction. Topical 5% guanethidine reduces this sympathetic overactivity, effectively lowering the upper eyelid position and improving the cosmetic appearance and corneal exposure associated with lid retraction. **Analysis of Incorrect Options:** * **A. Ptosis:** Guanethidine causes a "chemical ptosis" by relaxing Müller’s muscle. Therefore, it would worsen pre-existing ptosis rather than treat it. * **B. Neuro-paralytic keratitis:** This condition results from trigeminal nerve (CN V) palsy leading to loss of corneal sensation. Treatment focuses on lubrication and tarsorrhaphy, not sympatholytics. * **D. Horner's syndrome:** This condition is characterized by sympathetic denervation (resulting in ptosis and miosis). Guanethidine, being a sympatholytic, would mimic or exacerbate the signs of Horner's syndrome rather than treat it. (Note: Cocaine or Apraclonidine are typically used for the *diagnosis* of Horner's). **High-Yield Clinical Pearls for NEET-PG:** * **Müller’s Muscle:** Supplied by sympathetic fibers; its overaction causes lid retraction (Dalrymple’s sign) in Graves' disease. * **Guanethidine Side Effects:** Long-term topical use can cause superficial punctate keratitis (SPK) and conjunctival fibrosis. * **Other uses:** While historically used for glaucoma (to decrease aqueous production), it is now largely obsolete for that indication due to better alternatives. * **Thyroid Eye Disease:** The most common cause of both unilateral and bilateral proptosis in adults.
Explanation: **Explanation:** The correct answer is **Fungal corneal ulcer**. Topical steroids are strictly contraindicated in active fungal and pyogenic bacterial infections of the cornea. **Why Fungal Corneal Ulcer?** Steroids are potent immunosuppressants. In fungal keratitis, they inhibit the local inflammatory response and leukocyte migration, allowing fungi to proliferate unchecked. Furthermore, steroids can enhance the activity of collagenolytic enzymes, leading to rapid stromal melting and potential corneal perforation. **Analysis of Other Options:** * **Herpes Keratitis:** This is a nuanced area. While steroids are contraindicated in **epithelial** (dendritic) herpes simplex keratitis because they promote viral replication, they are actually the mainstay of treatment for **stromal** herpetic keratitis and disciform keratitis to reduce scarring. Since the option is broad, fungal ulcer remains the more absolute contraindication. * **Atopic Dermatitis:** Steroids are frequently used to manage the inflammatory components of atopic dermatitis and its ocular manifestations (atopic keratoconjunctivitis), provided there is no secondary infection. * **Exposure Keratitis:** The primary treatment is lubrication and protection (tarsorrhaphy). While steroids aren't the first line, they are not strictly contraindicated unless a secondary fungal or viral infection develops. **High-Yield Clinical Pearls for NEET-PG:** * **Steroid-Induced Glaucoma:** Occurs due to increased resistance to aqueous outflow at the trabecular meshwork (associated with the *MYOC* gene). * **Steroid-Induced Cataract:** Typically presents as **Posterior Subcapsular Cataract (PSC)**. * **Rule of Thumb:** Never prescribe steroids in a patient with a "red eye" until a corneal ulcer (specifically fungal or dendritic) has been ruled out via fluorescein staining.
Explanation: **Explanation:** **Choroidal Melanoma** is the most common primary intraocular malignancy in adults. The hallmark finding on **Fluorescein Angiography (FFA)** is **Double Circulation**, which is considered pathognomonic for this condition. 1. **Why "Double Circulation" is correct:** This phenomenon occurs due to the simultaneous visualization of two distinct vascular systems: the normal retinal vasculature overlying the tumor and the large, irregular, leaky vessels within the tumor itself (intrinsic tumor circulation). On FFA, these internal tumor vessels fluoresce independently of the overlying retinal vessels, creating the "double" appearance. 2. **Analysis of Incorrect Options:** * **A & B (Collar stud / Mushroom shape appearance):** These terms describe the **morphological (gross/ultrasound) shape** of the tumor, not the angiographic appearance. When a choroidal melanoma grows large enough to rupture through the **Bruch’s membrane**, it expands into the subretinal space, taking on a pedunculated, mushroom, or collar-stud configuration. While these are classic features of melanoma, they are seen on B-scan ultrasonography or clinical examination, not specifically defined as the FFA finding. **High-Yield Clinical Pearls for NEET-PG:** * **B-Scan Ultrasonography:** Shows a "solid" elevation with **acoustic shadowing**, **excavation of the underlying choroid**, and low-to-medium internal reflectivity (due to the cellular nature of the tumor). * **Most common site of metastasis:** Liver (Hematogenous spread). * **Treatment:** Small tumors are managed with plaque brachytherapy; large tumors or those with optic nerve involvement often require enucleation. * **Differential Diagnosis:** Choroidal hemangioma (shows early intense hyperfluorescence on FFA, unlike the slower filling in melanoma).
Explanation: **Explanation:** **Tetracyclines** (Option D) are widely used in ophthalmology as topical preparations (1% ointment). They are effective against a broad spectrum of bacteria and are particularly high-yield for NEET-PG as the drug of choice for **Trachoma** (caused by *Chlamydia trachomatis*). Beyond their antimicrobial properties, topical tetracyclines are used in managing **Meibomian Gland Dysfunction (MGD)** and blepharitis due to their ability to inhibit bacterial lipases and provide anti-inflammatory effects. **Why the other options are incorrect:** * **Erythromycin (A):** While erythromycin ophthalmic ointment exists globally, in the context of standard Indian pharmacopoeia and common clinical practice reflected in exams, it is less frequently used topically compared to Tetracyclines or Macrolides like Azithromycin. * **Ganciclovir (B):** Ganciclovir is an antiviral. While a topical gel formulation exists for Herpetic Keratitis, it is highly specialized. In the context of this specific question set, Tetracycline is the more "classic" topical agent. * **Clindamycin (C):** Clindamycin is primarily used systemically or topically for acne/skin infections. It is **not** used as a standard topical ophthalmic drop or ointment. **High-Yield Clinical Pearls for NEET-PG:** 1. **Trachoma Management:** The WHO "SAFE" strategy uses topical Tetracycline (1% ointment twice daily for 6 weeks) or a single dose of oral Azithromycin. 2. **Ocular Rosacea:** Tetracyclines (Doxycycline) are the systemic drug of choice for ocular rosacea. 3. **Contraindication:** Avoid systemic tetracyclines in children (<8 years) and pregnant women due to bone growth inhibition and tooth discoloration; however, **topical** use does not carry these systemic risks.
Explanation: **Explanation:** **Tropicamide** is the drug of choice for diagnostic fundoscopy because it is the **fastest and shortest-acting** topical antimuscarinic agent. It works by blocking the M3 receptors in the sphincter pupillae muscle, leading to passive mydriasis. * **Why Tropicamide is correct:** It has a rapid onset of action (15–20 minutes) and a short duration of effect (4–6 hours). This allows for a quick clinical examination while ensuring the patient’s vision returns to normal within the same day, minimizing the duration of photophobia and blurred vision. **Analysis of Incorrect Options:** * **Atropine:** The most potent cycloplegic with the longest duration of action (7–10 days). It is never used for routine fundoscopy due to prolonged recovery and risk of systemic toxicity in children. * **Homatropine:** A moderately long-acting agent (duration 2–3 days). It is primarily used in the treatment of anterior uveitis to prevent posterior synechiae and relieve ciliary spasm. * **Cyclopentolate:** Has a duration of 24 hours. While used for cycloplegic refraction in children, its effect lasts too long for routine diagnostic fundoscopy. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for Cycloplegic Refraction:** Atropine (children <7 years), Cyclopentolate (7–24 years), Homatropine (adults). * **Phenylephrine:** Often used in combination with Tropicamide to achieve maximal mydriasis (via alpha-1 stimulation of the dilator pupillae) without causing cycloplegia. * **Contraindication:** All mydriatics are contraindicated in patients with a narrow anterior chamber angle due to the risk of precipitating **Acute Angle Closure Glaucoma**.
Explanation: **Explanation:** The correct answer is **Fungal corneal ulcer**. Topical steroids are strictly contraindicated in most infectious keratitis, particularly fungal and herpetic epithelial keratitis. **Why Fungal Corneal Ulcer?** Steroids are potent immunosuppressants. In fungal keratitis (often caused by *Aspergillus* or *Fusarium*), steroids inhibit the local immune response, allowing the fungi to proliferate unchecked. Furthermore, steroids activate **matrix metalloproteinases (collagenases)**, which accelerate stromal melting and increase the risk of corneal perforation. **Analysis of Other Options:** * **Anterior & Posterior Uveitis:** Steroids are the **mainstay of treatment** here. They reduce intraocular inflammation, prevent the formation of synechiae, and stabilize the blood-aqueous barrier. * **Mooren’s Ulcer:** This is an idiopathic, peripheral ulcerative keratitis (PUK) of **autoimmune origin**. Since the underlying pathology is an overactive immune response attacking the corneal stroma, topical and sometimes systemic steroids are indicated to suppress the inflammation. **High-Yield Clinical Pearls for NEET-PG:** * **Steroid-Induced Glaucoma:** Steroids decrease aqueous outflow by causing structural changes in the trabecular meshwork (increased deposition of glycosaminoglycans). * **Steroid-Induced Cataract:** Typically presents as **Posterior Subcapsular Cataract (PSC)**. * **Dendritic Ulcer:** Topical steroids are also contraindicated in active Herpes Simplex epithelial keratitis as they promote viral replication, potentially turning a dendritic ulcer into a **geographic ulcer**. * **Rule of Thumb:** Never prescribe a steroid for a "red eye" unless a corneal epithelial defect (ulcer) has been ruled out using fluorescein staining.
Explanation: **Explanation:** **Natamycin (Option C)** is the drug of choice for the topical treatment of fungal keratitis (keratomycosis), particularly those caused by filamentous fungi like *Fusarium* and *Aspergillus*. It is a polyene antifungal that works by binding to ergosterol in the fungal cell membrane, leading to cell lysis. It is the only FDA-approved topical ophthalmic antifungal and is preferred due to its broad spectrum of activity and low ocular toxicity. **Analysis of Incorrect Options:** * **Silver sulfadiazine (Option A):** While it has some antifungal properties and was historically used in resource-limited settings, it is primarily an antibacterial agent used for burns and is not the first-line choice for corneal infections. * **Neomycin (Option B):** This is an aminoglycoside antibiotic. It is effective against bacteria but has no activity against fungi. * **Griseofulvin (Option D):** This is an oral antifungal used primarily for dermatophytosis (skin/hair/nails). It is ineffective against the common pathogens that cause fungal keratitis and is not used topically in the eye. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** Natamycin 5% suspension is the first-line treatment for **filamentous fungi** (common in agricultural trauma). * **Yeasts:** For *Candida* infections, topical **Amphotericin B (0.15%)** is often preferred over Natamycin. * **Deep Infections:** If the infection involves the deep stroma, Natamycin has poor penetration; in such cases, **Voriconazole** (topical or systemic) is the preferred alternative. * **Clinical Sign:** Fungal ulcers typically present with "feathery borders," "satellite lesions," and an immune "Wessely ring."
Explanation: ### Explanation Epinephrine (Adrenaline) is a non-selective sympathomimetic that acts on both alpha ($\alpha$) and beta ($\beta$) adrenergic receptors. Its effect on aqueous humor dynamics is unique because it exerts a **biphasic action**: 1. **Reduction of Aqueous Production:** By stimulating $\alpha$-receptors on the ciliary body epithelium, it causes vasoconstriction, which leads to a decrease in the ultrafiltration and active secretion of aqueous humor. 2. **Increase in Outflow Facility:** By stimulating $\beta_2$-receptors in the trabecular meshwork and uveoscleral pathways, it increases the ease with which aqueous humor exits the eye. Therefore, **Option C** is correct as it accounts for this dual mechanism of lowering intraocular pressure (IOP). **Analysis of Incorrect Options:** * **Option A & B:** These are incomplete. Epinephrine does not just reduce production; it simultaneously improves drainage. Furthermore, it *increases* (not reduces) outflow facility. * **Option D:** This is physiologically opposite to the therapeutic goal. Increasing production and reducing outflow would raise IOP, which is the opposite of what epinephrine does in a glaucomatous eye. **High-Yield Clinical Pearls for NEET-PG:** * **Dipivefrine:** A prodrug of epinephrine with better corneal penetration and fewer systemic side effects. * **Mydriasis:** Epinephrine causes pupillary dilation (via $\alpha_1$ receptors on the dilator pupillae). Thus, it is **contraindicated in Angle-Closure Glaucoma** as it can precipitate an acute attack. * **Adrenochrome Deposits:** Chronic use can lead to black, oxidative pigment deposits in the conjunctiva. * **Cystoid Macular Edema (CME):** A classic side effect of epinephrine/dipivefrine in **aphakic** patients.
Explanation: **Explanation:** **Hypertensive uveitis** is a condition where intraocular pressure (IOP) rises due to inflammation-induced trabeculitis or inflammatory debris clogging the trabecular meshwork. The management requires reducing IOP without exacerbating the underlying inflammation. **Why Dipivefrine is the correct answer:** Dipivefrine is a prodrug of **Epinephrine**. It reduces IOP by increasing aqueous outflow through the uveoscleral pathway and the trabecular meshwork (via $\beta_2$ receptors). Unlike miotics, it does not break the blood-aqueous barrier or cause ciliary muscle contraction, making it a safer choice among the provided options for managing pressure in an inflamed eye. **Why other options are incorrect:** * **Pilocarpine & Physostigmine (Miotics):** These are **contraindicated** in uveitis. Miotics cause ciliary muscle contraction, which increases pain and photophobia. More importantly, they break the blood-aqueous barrier, worsening inflammation, and promote the formation of **posterior synechiae** by bringing the iris into close contact with the lens. * **Latanoprost (Prostaglandin Analog):** While highly effective in primary glaucoma, PGAs are generally avoided in active uveitis. They are pro-inflammatory mediators and can exacerbate intraocular inflammation or trigger **Cystoid Macular Edema (CME)**. **Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for Hypertensive Uveitis:** Generally, **Beta-blockers** (Timolol) or **Carbonic Anhydrase Inhibitors** (Dorzolamide) are preferred first-line agents in modern practice. * **Avoid in Uveitis:** Miotics (Pilocarpine) and PGAs (Latanoprost). * **Posner-Schlossman Syndrome:** A classic cause of hypertensive uveitis characterized by recurrent episodes of very high IOP with minimal inflammation. * **Dipivefrine Fact:** It is 17 times more lipophilic than epinephrine, allowing better corneal penetration and fewer systemic side effects.
Ocular Pharmacokinetics
Practice Questions
Anti-infective Agents
Practice Questions
Anti-inflammatory Drugs
Practice Questions
Antiglaucoma Medications
Practice Questions
Mydriatics and Cycloplegics
Practice Questions
Ocular Lubricants
Practice Questions
Anti-VEGF Agents
Practice Questions
Ocular Diagnostic Agents
Practice Questions
Anesthetics in Ophthalmology
Practice Questions
Preservatives and Their Effects
Practice Questions
Ocular Toxicology
Practice Questions
Novel Drug Delivery Systems
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free